BiotechTube

Seroquel + Sugar Pill

Phase 3Completed
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Social Anxiety Disorder

Conditions

Social Anxiety Disorder

Trial Timeline

Oct 1, 2008 → Aug 1, 2013

NCT ID
NCT00773162

About Seroquel + Sugar Pill

Seroquel + Sugar Pill is a phase 3 stage product being developed by AstraZeneca for Social Anxiety Disorder. The current trial status is completed. This product is registered under clinical trial identifier NCT00773162. Target conditions include Social Anxiety Disorder.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT00773162Phase 3Completed

Competing Products

20 competing products in Social Anxiety Disorder

See all competitors
ProductCompanyStageHype Score
LY686017 + paroxetine + placeboEli LillyPhase 2
52
atomoxetine + placeboEli LillyPhase 2/3
65
ONO-1110 + PlaceboOno PharmaceuticalPhase 2
52
Cariprazine + PlaceboAbbVieApproved
85
QuetiapineAstraZenecaApproved
85
quetiapineAstraZenecaPhase 3
77
quetiapineAstraZenecaPhase 2/3
65
quetiapineAstraZenecaApproved
85
Pristiq + PlaceboPfizerApproved
84
Venlafaxine ERPfizerPhase 3
76
Ziprasidone + SertralinePfizerPhase 2
51
Sertraline + PlaceboPfizerApproved
84
NefazodoneBristol Myers SquibbApproved
84
EscitalopramLundbeckApproved
82
Cipralex + PlaceboLundbeckPhase 2
49
BHV-0223 + PlaceboBiohavenPhase 2/3
60
VQW-765 + PlaceboVanda PharmaceuticalsPhase 3
69
PH94BVistagen TherapeuticsPhase 3
69
Fasedienol Nasal Spray - Placebo Nasal Spray + Fasedienol Nasal Spray - Fasedienol Nasal Spray + Placebo Nasal Spray - Placebo Nasal SprayVistagen TherapeuticsPhase 2
44
PH94B Nasal Spray + Placebo Nasal SprayVistagen TherapeuticsPhase 3
69

Other Products from AstraZeneca

QuetiapineApproved
85
Dapagliflozin 5 mg + Placebo tabletApproved
85
QuetiapineApproved
85
Ticagrelor + ClopidogrelApproved
85
DurvalumabApproved
85